Effect of endogenous proteins on growth and antibody productivity in hybridoma batch cultures
- PMID: 7765957
- DOI: 10.1007/BF00762383
Effect of endogenous proteins on growth and antibody productivity in hybridoma batch cultures
Abstract
It has been shown that some B-cell hybridomas secrete autocrine factors in vitro which can influence cell metabolic processes. Rather than screen specifically for suspected cytokines, that may or may not affect our cell line, we have examined the lumped effects of intracellular and secreted factors on cell proliferation and monoclonal productivity in hybridoma batch cultures. Firstly, supplements of total soluble intracellular proteins combined with other intracellular metabolites were found to both decrease the specific growth rate and increase the antibody production rate at higher concentrations in batch culture. This is an important consideration in high cell density cultures, such as perfusion systems, where a reduction of growth by the presence of intracellular factors may be compensated by an increase in MAb production. In addition, flow cytometry data revealed that the average cell cycle G1 phase fraction was unaffected by the variation in the maximum specific growth rates during the exponential growth phase, caused by the addition of intracellular factors; this suggests that higher MAb productivity at lower growth rates are not a result of cell arrest in the G1 phase. Secondly, secreted extracellular proteins larger than 10,000 Daltons, which were concentrated from spent culture supernatant, were shown to have no significant effect on growth and specific MAb productivity when supplemented to batch culture at levels twice that encountered late in normal batch culture. This indicates that endogenous secreted cytokines, if at all present, do not play a major autocrine role for this cell line.
Similar articles
-
Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.Cytotechnology. 1992;9(1-3):85-97. doi: 10.1007/BF02521735. Cytotechnology. 1992. PMID: 1369185
-
The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.Biotechnol Prog. 1999 Jul-Aug;15(4):655-66. doi: 10.1021/bp990068m. Biotechnol Prog. 1999. PMID: 10441357
-
Cell growth, cell-cycle progress, and antibody production in hybridoma cells cultivated under mild hypothermic conditions.Hybridoma (Larchmt). 2008 Apr;27(2):107-11. doi: 10.1089/hyb.2007.0548. Hybridoma (Larchmt). 2008. PMID: 18642675
-
A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma.Adv Biochem Eng Biotechnol. 2004;87:61-96. doi: 10.1007/b94364. Adv Biochem Eng Biotechnol. 2004. PMID: 15217104 Review.
-
Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.Indian J Exp Biol. 1998 Feb;36(2):125-35. Indian J Exp Biol. 1998. PMID: 9754040 Review.
Cited by
-
Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.Cytotechnology. 1997 Jan;23(1-3):5-12. doi: 10.1023/A:1007959400666. Cytotechnology. 1997. PMID: 22358515 Free PMC article.